Back to investors
CRESTLINE MANAGEMENT, LP 13F Portfolio
CRESTLINE MANAGEMENT, LP
Latest SEC 13F filing: 2026-06-30
CRESTLINE MANAGEMENT, LP runs CRESTLINE MANAGEMENT, LP and currently holds 3 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $53.48M. Their top holdings are DNLI, SANA. The top five represent 96.8% of reported portfolio weight. CRESTLINE MANAGEMENT, LP ranks #N/A out of 1000 investors tracked by Alpha Score. They trimmed 1 position. Their current best-performing preview position is DNLI with returns of +33.96%.
Sign in to enable email alerts for this investor.
Top 5 Holdings
DNLI91.9%
SANA4.9%
Top 5: 96.8%
Portfolio Returns
1 Year
+76.90%
#0/10003 Year
+100.57%
#0/10005 Year
+70.98%
#0/1000Portfolio Value
$53.48M
Alpha Score
77.2
#0 of 1000
Holdings
3
Showper page
CRESTLINE MANAGEMENT, LP Current 13F Holdings
Reported holdings from CRESTLINE MANAGEMENT, LP's latest SEC 13F filing, ranked by portfolio weight.
3 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 DNLI DENALI THERAPEUTICS INC | 91.90% | $41.05 | $19.45 | -52.62% | Trimmed -13.57% |
 SANA SANA BIOTECHNOLOGY INC | 4.93% | $18.45 | $2.79 | -84.88% | Held |